ESC 365 - Mr Max Lenz

Speaker illustration

Mr Max Lenz

Medical University of Vienna, Vienna (Austria)

Member of:

Ranolazine induced modulation of intracellular Na+ concentration impacts inflammatory response and reduces atherosclerotic plaque progression

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Drugs, Drug Targets

Session: Late-Breaking Science - Poster session 2

Soluble neprilysin and survival in critically ill patients

Event: ESC Acute CardioVascular Care 2022

Topic: Biomarkers

Session: Intensive and Acute Cardiovascular Care

Soluble neprilysin and survival in critically ill patients

Event: ACVC 2021

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: ePoster session

Monocyte subset distribution predicts survival in patients with acute heart failure

Event: Acute Cardiovascular Care 2019

Topic: Biomarkers

Session: Acute Heart Failure – Diagnostic Methods

Toll-like receptor expression and mortality in critically ill patients

Event: Acute Cardiovascular Care 2019

Topic: Clinical

Session: Moderated Poster 2: Pulmonary, general ICU and organization of care

The role of TLR-9 in ischemia-reperfusion injury following acute myocardial infarction.

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Ventricular Remodelling

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Toll-like receptor expression and mortality in critical ill patients

Event: Acute Cardiovascular Care 2018

Topic: Acute Cardiac Care – CCU, Intensive, and Critical Cardiovascular Care

Session: Biomarkers

Additive prognostic value of copeptin and NT-proBNP in patients with acute heart failure

Event: ESC CONGRESS 2016

Topic: Acute intensive cardiovascular care

Session: Biomarkers and prognostication in acute cardiovascular care

This platform is supported by